← Back to guidelines
Oncology13 papers

Neoplasm of lumbar vertebral column

Last edited: 4/10/2026

Overview

Neoplasms of the lumbar vertebral column, particularly metastases, are increasingly encountered due to improved survival in cancer patients. Treatment aims are shifting from short-term palliation to long-term symptom or disease control 1.

Diagnosis

  • Selection of appropriate patients with painful spine metastases and oligometastatic disease is recommended for stereotactic body radiotherapy (SBRT) 1.
  • Management

  • Stereotactic body radiotherapy (SBRT) is a treatment option for spine metastases 1.
  • Technical planning aspects for spinal SBRT include dose and fractionation, patient positioning, immobilization, and image-guided delivery 1.
  • Quality assurance protocols are recommended for spinal SBRT 1.
  • Key Recommendations

  • SBRT is indicated for the treatment of painful spine metastases and oligometastatic disease 1. (Evidence: Expert opinion)
  • Technical planning for spinal SBRT should address dose and fractionation, patient positioning, immobilization, and image-guided delivery 1. (Evidence: Expert opinion)
  • Quality assurance protocols are necessary for the delivery of spinal SBRT 1. (Evidence: Expert opinion)
  • References

    1 Guckenberger M, Andratschke N, Belka C, Bellut D, Cuccia F, Dahele M et al.. ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2024. link

    Original source

    1. [1]
      ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases.Guckenberger M, Andratschke N, Belka C, Bellut D, Cuccia F, Dahele M et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG